Another Blow for Sanofi-Aventis as a Promising Drug Fails to Deliver
Sanofi-Aventis, which has been unsuccessful recently in its courtship of U.S. giant biotech Genzyme, announced another setback today. A late-stage trial of NV1FGF did not meet its primary goal of preventing a major amputation o…